FDA Import Refusal 799-2349069-5/10002/1 — AbbVie Deutschland GmbH & Co. KG
The FDA refused shipment 799-2349069-5/10002/1 from AbbVie Deutschland GmbH & Co. KG (Germany) on December 31, 2025. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- December 31, 2025
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 58MCY09 RISANKIZUMAB-RZAA
- Charges
- 75